|Date||4 December 2018|
|Title||In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform ( EU time zone)|
The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics. A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARDTM is based on functional genomics.
Registration URL: https://attendee.gotowebinar.com/register/6969929947157787137